Skip to main content

Table 3 Pregnancy outcome in uRM patients with or without lymphocyte immunotherapy

From: Low-dose lymphocyte immunotherapy rebalances the peripheral blood Th1/Th2/Treg paradigm in patients with unexplained recurrent miscarriage

 

Control Group

Immunotherapy Group

p value

Pregnancy

23(23/35)

43(43/64)

 

Delivery

14(60.87%)

32(74.42%)

0.068

≥20 weeks

1(4.35%)

5(11.63%)

Exfetation

0(0.00%)

1(2.32%)

Abortion

8(34.78%)

5(11.63%)

0.048